Treatment of Fulminant Hepatic Failure – Is There Light at the End of the Tunnel?
Author(s) -
K. Kaita
Publication year - 1995
Publication title -
canadian journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
eISSN - 2291-2797
pISSN - 2291-2789
DOI - 10.1155/1995/847146
Subject(s) - fulminant hepatic failure , fulminant , medicine , intensive care medicine , liver transplantation , randomized controlled trial , ideal (ethics) , bioartificial liver device , transplantation , clinical trial , surgery , hepatocyte , biology , political science , law , biochemistry , in vitro
A lot of research has been done on fulminant hepatic failure (FHF), mainly because of the high mortality associated with it. Many centres continue to search actively for the ideal medical treatment for FHF because liver transplantation is often difficult in these very ill patients. The many forms of therapy that have been tried and reported in case reports, small clinical trials and the occasional randomized controlled trial are reviewed, as are the current data on bioartificial livers and isolated hepatocyte transplantation. The ideal treatment remains elusive, and more work needs to be done to find a highly effective form of therapy for these very ill FHF patients
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom